Mucosal Immunity and Alternative Vaccine Routes

Mucosal vaccination targets primary pathogen entry sites, offering localized and systemic protection. Induction of secretory IgA enhances frontline immune defense at respiratory, gastrointestinal, and urogenital surfaces. Activation of mucosa-associated lymphoid tissue (MALT) improves antigen uptake and immune surveillance. Development of tissue-resident memory immune cells supports long-term localized immunity. These strategies reduce transmission, improve compliance, and strengthen barrier immunity through non-invasive delivery approaches.

Mucosal Defense:

  • Secretory Immunity
  • Local Memory
  • Non-Invasive Routes

    Related Conference of Mucosal Immunity and Alternative Vaccine Routes

    March 16-17, 2026

    8th World Congress on Vaccine and Immunology

    Paris, France
    September 21-22, 2026

    44th Euro Global Summit and Expo on Vaccines & Vaccination

    Barcelona, Spain

    Mucosal Immunity and Alternative Vaccine Routes Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in